Related Experiment Videos
The function of the NMDA-receptor during normal brain aging
W E Müller1, S Stoll, K Scheuer
1Department of Psychopharmacology, Central Institute of Mental Health, Mannheim, Federal Republic of Germany.
Journal of Neural Transmission. Supplementum
|January 1, 1994
Summary
Aging may decrease N-methyl-D-aspartate (NMDA) receptor density, contributing to cognitive decline. Strategies like glycine site agonists or nootropics aim to restore NMDA receptor function and improve aging cognition.
Area of Science:
- Neuroscience
- Aging Research
- Pharmacology
Background:
- Age-related decline in N-methyl-D-aspartate (NMDA) receptor density is observed in brain regions like the cortex and hippocampus.
- Reduced NMDA receptor density is hypothesized to be a key factor in age-associated cognitive impairment.
Purpose of the Study:
- To explore strategies for improving cognitive function in aging by addressing NMDA receptor deficits.
- To investigate therapeutic approaches targeting glutamatergic neurotransmission and NMDA receptor density.
Main Methods:
- Review of experimental observations and existing literature on NMDA receptor changes with age.
- Analysis of therapeutic strategies involving indirect activation of glutamatergic neurotransmission.
- Evaluation of nootropic agents for restoring age-related NMDA receptor deficits.
Main Results:
- Age-related decrease in NMDA receptor density is a documented phenomenon.
- Several strategies show promise in compensating for these deficits to enhance cognition.
- Indirect activation of glutamatergic neurotransmission and receptor density restoration are key approaches.
Conclusions:
- Targeting NMDA receptor deficits represents a viable strategy for combating age-related cognitive decline.
- Glycine site agonists and specific nootropics are promising therapeutic avenues.
- Further research into these interventions could lead to effective cognitive enhancers for aging populations.